News

One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects.
As founder of HUYA Bioscience International, Lady Mireille Gillings built a pioneering model to accelerate the global development of novel biopharmaceutical therapies originating in China.
The administration of US President Donald Trump has taken a series of actions since January, 2025 that directly threaten the foundations of health care, for global and US citizens alike. What started ...
PM: Great scientists, such as Pasteur (of course), Einstein ... and he has been a lecturer in pharmaceutical and biotechnology industry seminars and in business schools for several years.
Ambassador Brochet outlines shared goals in innovation, trade, and cultural growth as President Macron visits Vietnam.
The much-anticipated second annual edition of the Biotechnology Show continues to attract industry giants, creating a powerful platform for innovation, collaboration, and deal-making. With an ...
PDS Biotechnology Corporation (NASDAQ:PDSB) unveiled compelling new data on its Versamune HPV (PDS0101) immunotherapy at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.
This fund holds a portfolio of 75-125 biotechnology stocks, balanced between established large-cap names and smaller companies with more growth potential but also more risk. The managers aim to ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Thanks to his contributions to the field, he is sometimes known as the father of bacteriology, a title shared with Louis Pasteur. Koch’s first important discovery was on anthrax, a disease that ...
Modern biotechnology began in 1973 when scientists used recombination to genetically engineer an antibiotic-resistant strain of Escherichia coli bacteria. This began a revolution in molecule ...